Tilray Brands' subsidiary CC Pharma has been recognized as a TOP 100 Innovator in Germany, highlighting its role in the European pharmaceutical and medical cannabis markets. Breckenridge Distillery, ...

The global cannabis use disorder market is rapidly expanding, driven by increased recognition of cannabis use as a public health issue and the ongoing development of investigational treatments, ...

WASHINGTON, DC / ACCESS Newswire / November 16, 2025 / As Congress moves decisively to end the era of intoxicating hemp products and synthetic cannabinoids, a new chapter is opening for federally ...

CC Pharma’s selection as a TOP 100 Innovator reflects its disciplined innovation strategy, strong regional footprint, and commitment to operational excellence in a highly regulated market. The award ...

In Chefchaouen, a pharmaceutical unit dedicated 100% to the valorization of legal cannabis is currently being developed.

TORONTO, April 03, 2023 (GLOBE NEWSWIRE) -- Mindset Pharma Inc. (CSE: MSET) (FSE: 9DF) (OTCQB: MSSTF) (“Mindset” or the “Company”), a drug discovery company ...

CEO Aspen Noonan: "Plant-Medicine Is Not a Niche. It's a Reckoning." In 2025, 24 states plus Washington D.C. have legalized adult-use cannabis, while nearly every other state allows medical access.

Brazil's medical cannabis program is set to expand, with cultivation legalized for the first time in Latin America's largest ...

For decades, cannabis has been trapped in a political purgatory, classified, vilified, and regulated as if it were a dangerous, single-molecule synthetic drug. But anyone who’s ever looked beyond the ...

Simultaneously, state and federal law enforcement agencies-including the Hillsborough County, Tampa, Florida Sheriff's Office-have begun sweeping raids on convenience stores selling synthetic ...